Philip Lambert

Philip Lambert has an extensive background in the pharmaceutical and biotech industry, with experience in leading scientific efforts at various companies such as Satellos Bioscience Inc., Libra Therapeutics, and CENTOGENE. Their work has focused on developing treatments for rare diseases and driving advancements in muscle regeneration. With a PhD in Neuropharmacology from Imperial College London and a Post-doc in Psychiatry from Emory University School of Medicine, Philip brings a wealth of scientific expertise to their role as Chief Scientific Officer.